CA Stock MarketDetailed Quotes

UniDoc Health Corp (UDOC)

Watchlist
  • 0.090
  • 0.0000.00%
15min DelayMarket to Open May 4 15:55 ET
7.80MMarket Cap-2.25P/E (TTM)

UniDoc Health Corp (UDOC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.70%-1.16M
82.34%-270.62K
76.28%-543.69K
-1,221.20%-7.4M
-7,969.80%-1.01M
-1,710.84%-2.56M
-334.59%-1.53M
-2,817.11%-2.29M
25.90%-559.92K
144.69%12.82K
Net income from continuing operations
60.30%-611.41K
46.32%-875.77K
66.26%-642.46K
-168.31%-6.06M
-25.49%-987.63K
-373.60%-1.54M
-269.71%-1.63M
-169.61%-1.9M
-66.52%-2.26M
-84.98%-787.04K
Operating gains losses
---11.48K
--7.63K
---28.62K
----
----
----
----
----
---30.96K
----
Depreciation and amortization
387.39%46.37K
392.76%44.35K
394.34%43.99K
-44.96%37.57K
11,849.41%10.16K
-64.77%9.51K
-58.92%9K
-53.81%8.9K
6.29%68.26K
-99.53%85
Asset impairment expenditure
----
----
----
57.92%116.43K
----
----
----
----
--73.73K
----
Unrealized gains and losses of investment securities
----
----
---7.13K
----
----
----
----
--0
----
----
Remuneration paid in stock
--0
--0
--0
-96.02%14.59K
--0
--0
--0
-96.41%14.59K
--366.62K
---13.77K
Other non cashItems
-8,885.01%-34K
8,087.57%42.17K
595.87%4.89K
2,850.03%95.88K
12,190.87%94.27K
-53.37%387
-42.52%515
-7.13%703
109.35%3.25K
--767
Change In working capital
42.23%-597.76K
459.71%503.87K
120.78%85.65K
-231.14%-1.6M
-131.40%-241.75K
-764.68%-1.03M
-2.45%90.02K
-305.00%-412.17K
113.12%1.22M
86.20%770K
-Change in receivables
185.23%73.43K
-402.08%-156.4K
7.60%-92.25K
-344.51%-114.91K
-80.83%19.3K
-307.30%-86.15K
376.74%51.78K
-622.41%-99.84K
318.44%47K
951.77%100.68K
-Change in inventory
123.24%21.25K
--61.68K
---82.93K
-159.97%-84.09K
156.61%7.37K
---91.45K
--0
--0
---32.35K
---13.02K
-Change in prepaid assets
9.05%-347.62K
333.61%348.55K
266.13%122.83K
-3,005.63%-621.84K
-558.98%-246.06K
-24,353.17%-382.23K
206.88%80.38K
---73.93K
-122.40%-20.02K
-36.53%53.61K
-Change in payables and accrued expense
51.65%-229.63K
666.93%238.87K
165.09%155.18K
-163.53%-777.83K
-103.56%-22.35K
-344.08%-474.94K
-122.63%-42.13K
-210.95%-238.4K
142.87%1.22M
84.44%628.72K
-Change in other working capital
---115.19K
--11.17K
---17.17K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
54.70%-1.16M
82.34%-270.62K
76.28%-543.69K
-1,221.20%-7.4M
-7,969.80%-1.01M
-1,710.84%-2.56M
-334.59%-1.53M
-2,817.11%-2.29M
25.90%-559.92K
144.69%12.82K
Investing cash flow
Cash flow from continuing investing activities
0
-2,835.60%-72.16K
-1.23K
-257.76K
-252.43K
-2.87K
-2.46K
0
0
0
Net PPE purchase and sale
--0
-2,835.60%-72.16K
---1.23K
---5.33K
--0
---2.87K
---2.46K
--0
--0
--0
Net intangibles purchas and sale
----
----
----
---252.43K
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
--0
-2,835.60%-72.16K
---1.23K
---257.76K
---252.43K
---2.87K
---2.46K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-68.82%1.46M
-100.59%-10.68K
-100.52%-10.46K
837.73%8.51M
-83.37%50.63K
33,020.89%4.67M
239.77%1.8M
3,247.62%1.99M
5,850.70%907.48K
808.62%304.49K
Net issuance payments of debt
3.06%-12.15K
63.15%-12.15K
0.01%-12.15K
-188.86%-66.98K
16.37%-9.32K
-14.92%-12.54K
-208.76%-32.98K
-227.41%-12.15K
-252.05%-23.19K
-133.24%-11.14K
Proceeds from stock option exercised by employees
--0
--0
--0
873.89%8.58M
-76.85%61.5K
18,618.67%4.68M
281.40%2.06M
3,451.76%1.78M
--880.67K
--265.63K
Net other financing activities
-12,360.38%-32.49K
100.65%1.47K
-99.26%1.69K
----
----
--265
---228.12K
--229.42K
--50K
----
Cash from discontinued financing activities
Financing cash flow
-68.82%1.46M
-100.59%-10.68K
-100.52%-10.46K
837.73%8.51M
-83.37%50.63K
33,020.89%4.67M
239.77%1.8M
3,247.62%1.99M
5,850.70%907.48K
808.62%304.49K
Net cash flow
Beginning cash position
-5.34%344.38K
600.33%697.84K
214.18%1.25M
677.21%398.89K
2,919.63%2.46M
73.96%363.8K
208.71%99.65K
677.21%398.89K
-93.99%51.32K
-11.60%81.58K
Current changes in cash
-86.03%293.43K
-233.81%-353.46K
-85.60%-555.38K
145.81%854.33K
-481.44%-1.21M
1,746.30%2.1M
49.37%264.16K
-1,471.23%-299.24K
143.28%347.56K
874.51%317.3K
End cash Position
-74.11%637.81K
-5.34%344.38K
600.33%697.84K
214.18%1.25M
214.18%1.25M
2,919.63%2.46M
73.96%363.8K
208.71%99.65K
677.21%398.89K
677.21%398.89K
Free cash from
54.75%-1.16M
77.66%-342.78K
76.23%-544.92K
-1,267.24%-7.66M
-9,939.60%-1.26M
-1,712.87%-2.57M
-335.29%-1.53M
-2,817.11%-2.29M
31.58%-559.92K
117.21%12.82K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.70%-1.16M82.34%-270.62K76.28%-543.69K-1,221.20%-7.4M-7,969.80%-1.01M-1,710.84%-2.56M-334.59%-1.53M-2,817.11%-2.29M25.90%-559.92K144.69%12.82K
Net income from continuing operations 60.30%-611.41K46.32%-875.77K66.26%-642.46K-168.31%-6.06M-25.49%-987.63K-373.60%-1.54M-269.71%-1.63M-169.61%-1.9M-66.52%-2.26M-84.98%-787.04K
Operating gains losses ---11.48K--7.63K---28.62K-----------------------30.96K----
Depreciation and amortization 387.39%46.37K392.76%44.35K394.34%43.99K-44.96%37.57K11,849.41%10.16K-64.77%9.51K-58.92%9K-53.81%8.9K6.29%68.26K-99.53%85
Asset impairment expenditure ------------57.92%116.43K------------------73.73K----
Unrealized gains and losses of investment securities -----------7.13K------------------0--------
Remuneration paid in stock --0--0--0-96.02%14.59K--0--0--0-96.41%14.59K--366.62K---13.77K
Other non cashItems -8,885.01%-34K8,087.57%42.17K595.87%4.89K2,850.03%95.88K12,190.87%94.27K-53.37%387-42.52%515-7.13%703109.35%3.25K--767
Change In working capital 42.23%-597.76K459.71%503.87K120.78%85.65K-231.14%-1.6M-131.40%-241.75K-764.68%-1.03M-2.45%90.02K-305.00%-412.17K113.12%1.22M86.20%770K
-Change in receivables 185.23%73.43K-402.08%-156.4K7.60%-92.25K-344.51%-114.91K-80.83%19.3K-307.30%-86.15K376.74%51.78K-622.41%-99.84K318.44%47K951.77%100.68K
-Change in inventory 123.24%21.25K--61.68K---82.93K-159.97%-84.09K156.61%7.37K---91.45K--0--0---32.35K---13.02K
-Change in prepaid assets 9.05%-347.62K333.61%348.55K266.13%122.83K-3,005.63%-621.84K-558.98%-246.06K-24,353.17%-382.23K206.88%80.38K---73.93K-122.40%-20.02K-36.53%53.61K
-Change in payables and accrued expense 51.65%-229.63K666.93%238.87K165.09%155.18K-163.53%-777.83K-103.56%-22.35K-344.08%-474.94K-122.63%-42.13K-210.95%-238.4K142.87%1.22M84.44%628.72K
-Change in other working capital ---115.19K--11.17K---17.17K----------------------------
Cash from discontinued investing activities
Operating cash flow 54.70%-1.16M82.34%-270.62K76.28%-543.69K-1,221.20%-7.4M-7,969.80%-1.01M-1,710.84%-2.56M-334.59%-1.53M-2,817.11%-2.29M25.90%-559.92K144.69%12.82K
Investing cash flow
Cash flow from continuing investing activities 0-2,835.60%-72.16K-1.23K-257.76K-252.43K-2.87K-2.46K000
Net PPE purchase and sale --0-2,835.60%-72.16K---1.23K---5.33K--0---2.87K---2.46K--0--0--0
Net intangibles purchas and sale ---------------252.43K------------------0----
Cash from discontinued investing activities
Investing cash flow --0-2,835.60%-72.16K---1.23K---257.76K---252.43K---2.87K---2.46K--0--0--0
Financing cash flow
Cash flow from continuing financing activities -68.82%1.46M-100.59%-10.68K-100.52%-10.46K837.73%8.51M-83.37%50.63K33,020.89%4.67M239.77%1.8M3,247.62%1.99M5,850.70%907.48K808.62%304.49K
Net issuance payments of debt 3.06%-12.15K63.15%-12.15K0.01%-12.15K-188.86%-66.98K16.37%-9.32K-14.92%-12.54K-208.76%-32.98K-227.41%-12.15K-252.05%-23.19K-133.24%-11.14K
Proceeds from stock option exercised by employees --0--0--0873.89%8.58M-76.85%61.5K18,618.67%4.68M281.40%2.06M3,451.76%1.78M--880.67K--265.63K
Net other financing activities -12,360.38%-32.49K100.65%1.47K-99.26%1.69K----------265---228.12K--229.42K--50K----
Cash from discontinued financing activities
Financing cash flow -68.82%1.46M-100.59%-10.68K-100.52%-10.46K837.73%8.51M-83.37%50.63K33,020.89%4.67M239.77%1.8M3,247.62%1.99M5,850.70%907.48K808.62%304.49K
Net cash flow
Beginning cash position -5.34%344.38K600.33%697.84K214.18%1.25M677.21%398.89K2,919.63%2.46M73.96%363.8K208.71%99.65K677.21%398.89K-93.99%51.32K-11.60%81.58K
Current changes in cash -86.03%293.43K-233.81%-353.46K-85.60%-555.38K145.81%854.33K-481.44%-1.21M1,746.30%2.1M49.37%264.16K-1,471.23%-299.24K143.28%347.56K874.51%317.3K
End cash Position -74.11%637.81K-5.34%344.38K600.33%697.84K214.18%1.25M214.18%1.25M2,919.63%2.46M73.96%363.8K208.71%99.65K677.21%398.89K677.21%398.89K
Free cash from 54.75%-1.16M77.66%-342.78K76.23%-544.92K-1,267.24%-7.66M-9,939.60%-1.26M-1,712.87%-2.57M-335.29%-1.53M-2,817.11%-2.29M31.58%-559.92K117.21%12.82K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More